News Headlines Article

Merck will pay $950M to settle Vioxx investigation
USA Today

Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx, the U.S. Justice Department said Tuesday The agency says Merck (MRK) will pay $321.6 million in criminal fines and $628.4 million as a civil settlement agreement. It will also plead guilty to a misdemeanor charge that it marketed Vioxx as a treatment for rheumatoid arthritis before getting Food and Drug Administration approval.